Oncogene - Table of Contents alert Volume 37 Issue 31

If you are unable to see the message below, click here to view.

` TABLE OF CONTENTS Volume 37, Issue 31 In this issue Article Brief Communications Also new AOP Article A kinome-wide high-content siRNA screen identifies MEK5–ERK5 signaling as critical for breast cancer cell EMT and metastasis Simona Pavan, Nathalie Meyer-Schaller, Maren Diepenbruck, Ravi Kiran Reddy Kalathur, Meera Saxena et al. Oncogene 2018 37 :4197 - 4213; May 01, 2018; 10.1038/s41388-018-0270-8 Abstract | Full Text Intermittent hypoxia induces a metastatic phenotype in breast cancer Anna Chen, Jaclyn Sceneay, Nathan Gödde, Tanja Kinwel, Sunyoung Ham et al. Oncogene 2018 37 :4214 - 4225; May 01, 2018; 10.1038/s41388-018-0259-3 Abstract | Full Text A modified gene trap approach for improved high-throughput cancer drug discovery Shelli M. Morris, Andrew J. Mhyre, Savanna S. Carmack, Carrie H. Myers, Connor Burns et al. Oncogene 2018 37 :4226 - 4238; May 02, 2018; 10.1038/s41388-018-0274-4 Abstract | Full Text Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways Xiaofan Guo, Wei Qiu, Qinglin Liu, Mingyu Qian, Shaobo Wang et al. Oncogene 2018 37 :4239 - 4259; May 01, 2018; 10.1038/s41388-018-0261-9 Abstract | Full Text Inactivation of the serine protease HTRA1 inhibits tumor growth by deregulating angiogenesis Ralph Klose, M. Gordian Adam, Eva-Maria Weis, Iris Moll, Joycelyn Wüstehube-Lausch et al. Oncogene 2018 37 :4260 - 4272; May 01, 2018; 10.1038/s41388-018-0258-4 Abstract | Full Text Ubiquitylation and degradation of adenomatous polyposis coli by MKRN1 enhances Wnt/ß-catenin signaling Hae-Kyung Lee, Eun-Woo Lee, Jinho Seo, Manhyung Jeong, Seon-Hyeong Lee et al. Oncogene 2018 37 :4273 - 4286; May 01, 2018; 10.1038/s41388-018-0267-3 Abstract | Full Text Glycosylation controls cooperative PECAM-VEGFR2-ß3 integrin functions at the endothelial surface for tumor angiogenesis Rie Imamaki, Kazuko Ogawa, Yasuhiko Kizuka, Yusuke Komi, Soichi Kojima et al. Oncogene 2018 37 :4287 - 4299; May 02, 2018; 10.1038/s41388-018-0271-7 Abstract | Full Text Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin ß3 Jinnan Yue, Dacheng Lv, Caiyun Wang, Ling Li, Qingnan Zhao et al. Oncogene 2018 37 :4300 - 4312; May 02, 2018; 10.1038/s41388-018-0276-2 Abstract | Full Text Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades Ningning Li, Ying Zhang, Kastytis Sidlauskas, Matthew Ellis, Ian Evans et al. Oncogene 2018 37 :4313 - 4333; May 03, 2018; 10.1038/s41388-018-0277-1 Abstract | Full Text Brief Communications Pre-neoplastic pancreas cells enter a partially mesenchymal state following transient TGF-ß exposure Jesse Handler, Jane Cullis, Antonina Avanzi, Emily A. Vucic & Dafna Bar-Sagi Oncogene 2018 37 :4334 - 4342; May 01, 2018; 10.1038/s41388-018-0264-6 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.